Cone-rod dystrophy is a heterogeneous group of inherited retinal diseases characterized by cone photoreceptor degeneration, which could be followed by subsequent rod photoreceptor loss. These disorders typically present with progressive loss of central vision, color vision disturbance, and photophobia.
This report contains market size and forecasts of Cone-rod Dystrophy Treatment in Global, including the following market information:
Global Cone-rod Dystrophy Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Cone-rod Dystrophy Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Gene Therapy Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Cone-rod Dystrophy Treatment include GlaxoSmithKline, Johnson and Johnson, Sanofi, Pfizer, Novartis and Abbott Laboratories, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cone-rod Dystrophy Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cone-rod Dystrophy Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Cone-rod Dystrophy Treatment Market Segment Percentages, by Type, 2021 (%)
Gene Therapy
Stem Cell Therapy
Surgery For Retinal Implants
Other
Global Cone-rod Dystrophy Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Cone-rod Dystrophy Treatment Market Segment Percentages, by Application, 2021 (%)
Hospitals
Ophthalmic Centers
Research Organizations and Academic Institutes
Global Cone-rod Dystrophy Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Cone-rod Dystrophy Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cone-rod Dystrophy Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Cone-rod Dystrophy Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
GlaxoSmithKline
Johnson and Johnson
Sanofi
Pfizer
Novartis
Abbott Laboratories